PNC Financial Services Group’s NewAmsterdam Pharma NAMS Stock Holding History

PNC Financial Services Group’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Sell	7,291 -1,828	-20%	-$60.2K	﹤0.01%	2307
2026 Q1	$292K	Buy	9,119 +5,437	+148%	+$177K	﹤0.01%	2063
2025 Q4	$129K	Buy	3,682 +66	+2%	+$2.4K	﹤0.01%	2635
2025 Q3	$103K	Sell	3,616 -978	-21%	-$23.4K	﹤0.01%	2786
2025 Q2	$83.2K	Sell	4,594 -74	-2%	-$1.35K	﹤0.01%	2832
2025 Q1	$95.6K	Buy	4,668 +267	+6%	+$5.93K	﹤0.01%	2693
2024 Q4	$113K	Sell	4,401 -42	-0.9%	-$892	﹤0.01%	2608
2024 Q3	$73.8K	Buy	4,443 +1,769	+66%	+$30.6K	﹤0.01%	2855
2024 Q2	$51.4K	Buy	+2,674	New	+$53.6K	﹤0.01%	3019

Other funds holding NAMS

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

PNC Financial Services Group's NAMS Position: Q2 2026 in Review

PNC Financial Services Group reduced its NewAmsterdam Pharma (NAMS) stake by 20% in Q2 2026, selling an estimated $60.2K and leaving 7,291 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

PNC Financial Services Group first reported a position in NAMS in Q2 2024 and has held it in 9 quarters since. The position peaked at $292K in Q1 2026. 79 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

PNC Financial Services Group held 7,291 shares of NewAmsterdam Pharma worth $247K as of Q2 2026.
PNC Financial Services Group sold 1,828 NewAmsterdam Pharma shares in Q2 2026, an estimated $60.2K.
NewAmsterdam Pharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2307 holding.
PNC Financial Services Group first reported a position in NewAmsterdam Pharma in Q2 2024 and has held it in 9 quarters since.
PNC Financial Services Group's NewAmsterdam Pharma position peaked at $292K in Q1 2026.
79 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.